Bruton-Tyrosinkinasehemmer - die nächste Klasse von MS-Mitteln?
Crossref DOI link: https://doi.org/10.1007/s15202-021-4691-9
Published Online: 2021-06-10
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Thomas
Text and Data Mining valid from 2021-06-01
Version of Record valid from 2021-06-01
Article History
First Online: 10 June 2021